November 23, 2019
1 min read

Smith & Nephew announces third-quarter 2019 trading report

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Smith & Nephew announced its 2019 third-quarter trading report, stating positive momentum across all three of their global franchises.

“We’re pleased to have delivered organic revenue growth of 4% in the third quarter, a further step towards growing at or above our markets,” Graham Baker, chief financial officer of Smith & Nephew, said in the release.

The third-quarter revenue had an increase of 4%, with orthopedics increasing by 3.4%, sports medicine and ear, nose and throat by 6.9% revenue growth and advanced wound management by 2.1%. Full-year guidance for 2019 estimated underlying revenue growth to be in the 3.5% to 4.5% range and trading profit margins to be around 22.8%.

“We’ve built momentum across the first 9 months of the year and, at the same time, continued to invest behind our commercial teams and acquisitions to support sustained success over the medium-term,” Baker said in the release. “As a result, we’re confident to increase 2019 revenue guidance again.”